We develop and manufacture your biopharmaceutical drug candidate – reliably and rapidly. Our innovative technologies can elevate your product to the highest yield, potency, quality, and safety levels.
We are a Contract Development and Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. Our proprietary technologies accelerate and advance the development of drug candidates – from their inception to industrial market-readiness.
Therapeutic Proteins & Antibodies
Whether you want to produce an antibody, a therapeutic enzyme, or a virus, ProBioGen is your trusted and highly experienced partner for development and manufacturing. Starting with unique cell lines and all the way to scalable production, our process is tailored to your individual requirements. Expect best-in-class efficiency and competitive timelines combined with excellent customer service. We commit to top results and transparency at every stage.
GMP Production Cell Lines
Get the best-performing, stable production cell line, customized to your specific molecule. Highest quality, delivered on time.
GMP Production Cell Lines
Process Development
High performance, fully scalable from mg to kg
Process Development
Virus Production Development
Benefit from our virus, cell line, and process experience.
Virus Production Development
GMP Manufacturing
Quality – consistency – compliance
GMP Manufacturing
Biosimilars & Biobetters
Accelerate market entry with a top performing protein
Biosimilars & Biobetters
Analytics / Bioassays
Leading-edge assays that reveal everything about your protein
Analytics / Bioassays
Innovative Technologies
Enhancing the performance of antibodies by stripping them of fucose, linking antibodies to their drug loads at multiple targeted sites, testing the recombinant protein’s immunogenicity and function in-vitro, increasing productivity to unprecedented levels, or even boosting your viral vector or vaccine – our innovative technologies make those wishes your reality.
Genetic Glyco-Engineering/ ADCC (GlymaxX®)
Boost your antibodies’ potency with our GlymaxX ADCC enhancement technology
Genetic Glyco-Engineering/ ADCC (GlymaxX®)
DirectedLuck® Transposase with Epigenetic Targeting
Give your protein a ride on a cellular engine
DirectedLuck® Transposase with Epigenetic Targeting
Productivity Increase
One gene to boost them all – see how you can optimize your titers with our proven Pathway Modulator
Productivity Increase
Viral Vector Technologies
ProBioGen's MVA platform – the most efficient production system for a potent vaccine vector
Viral Vector Technologies
Virus Production Cell Lines
A scalable cell line is the bedrock of industrial production. See what our high-yield lines can do for your virus or vector!
Virus Production Cell Lines
Lenti.RiGHT® Lentivirus Packaging and Producer Cell Line
Enables a scalable production of high-titer lentiviral particles for gene transfer applications.
Lenti.RiGHT® Lentivirus Packaging and Producer Cell Line
Dr Thomas Rose, Head of Expression Systems at ProBioGen, will hold a 15-minute presentation on "DirectedLuck®: Transposase targeting and Transposon design push expression beyond limits" in the track "Engineering Antibodies & Beyond" on Wednesday, November 6th at 17:15 CET
Do not miss our poster #B087 "DirectedLuck® Transposase Targeting and Transposon Design push Expression beyond Limits", which will be presented in poster session B, Wednesday November 6th - Thursday November 7th
Are you looking to enhance your program or are you just curious about our company, services, and technologies? Connect with our team and we will get back to you shortly.